HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract.

AbstractBACKGROUND:
Urothelial carcinoma (UC) originating from the bladder (UBUC) and upper urinary tract (UTUC) is the most common type of urinary tract tumor. While its pathogenesis remains obscured. Computerizing a published transcriptomic database of UBUC (GSE31684), we identified Inhibin, Beta A (INHBA) as the most significant upregulated gene associated with tumor progression among those associated with growth factor activity (GO:0008083). We therefore analyzed the clinicopathological significance of INHBA expression in UC.
DESIGN:
QuantiGene assay was used to detect INHBA transcript level in 36 UTUCs and 30 UBUCs. Immunohistochemistry evaluated by H-score was used to determine INHBA protein expression in 340 UTUCs and 296 UBUCs. INHBA expression was correlated with clinicopathological features and disease-specific survival (DSS) and metastasis-free survival (MeFS).
RESULTS:
Increments of INHBA transcript level was associated with higher pT status in both UTUC and UBUC. INHBA protein overexpression was significantly associated with advanced clinicopathological features in both groups of UC. INHBA overexpression significantly implied inferior DSS (UTUC, P = 0.002; UBUC, P = 0.005) and MeFS (UTUC and UBUC, both P < 0.001) in multivariate analysis.
CONCLUSION:
INHBA overexpression implies adverse clinical outcomes for UC, justifying it is a potential prognostic biomarker and a novel therapeutic target in UC.
AuthorsHsiang-Ying Lee, Ching-Chia Li, Chun-Nung Huang, Wei-Ming Li, Hsin-Chih Yeh, Hung-Lung Ke, Kai-Fu Yang, Peir-In Liang, Chien-Feng Li, Wen-Jeng Wu
JournalJournal of surgical oncology (J Surg Oncol) Vol. 111 Issue 4 Pg. 414-22 (Mar 15 2015) ISSN: 1096-9098 [Electronic] United States
PMID25488476 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2014 Wiley Periodicals, Inc.
Chemical References
  • RNA, Messenger
  • inhibin beta A subunit
  • Inhibin-beta Subunits
Topics
  • Aged
  • Carcinoma (metabolism, mortality, pathology, therapy)
  • Female
  • Gene Expression Profiling
  • Humans
  • Immunohistochemistry
  • Inhibin-beta Subunits (genetics, metabolism)
  • Lymphatic Metastasis
  • Male
  • Mitosis
  • Neoplasm Invasiveness
  • Prognosis
  • RNA, Messenger (metabolism)
  • Up-Regulation
  • Urinary Bladder Neoplasms (metabolism, mortality, pathology, therapy)
  • Urologic Neoplasms (metabolism, mortality, pathology, therapy)
  • Urothelium (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: